| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | CNY 325.6M | +6.4% |
| Gross Profit | CNY 4.67B | −16.0% |
| EBITDA | CNY 953.9M | −20.6% |
| Net Income | CNY 1.44B | −14.2% |
| Diluted EPS | CNY 2.93 | −12.0% |
| Free Cash Flow | CNY 771.4M | −37.4% |
| DPS (FY2025) | $3.14derived |
| Trailing yield | 13.64% |
| Payout ratio | 102.7% |
| Growth streak | 3 yrs |
| 5y DPS growth | 18.2% |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | $3.14 | +3.1% | derived (paid ÷ diluted shares) |
| FY20242024-12-31 | $3.04 | +204.5% | derived (paid ÷ diluted shares) |
| FY20232023-12-31 | $1.00 | +18.4% | derived (paid ÷ diluted shares) |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | 88.90% | −151.26% | −445.24% | −950.68% | −384.78% | −447.92% | 25% | 1% | |
| Operating Margin | 36.36% | 427.19% | 550.69% | 846.44% | 327.99% | 236.29% | 25% | 99% | |
| EBITDA Margin | 38.32% | 501.29% | 685.41% | 1028.36% | 392.69% | 293.01% | 25% | 99% | |
| NOPAT Margin | 33.68% | 420.52% | 550.69% | 815.86% | 315.74% | 214.43% | 25% | 99% | |
| Net Margin | 37.83% | 539.21% | 818.92% | 1440.20% | 549.46% | 443.18% | 25% | 98% | |
| FCF Margin | 35.36% | 792.50% | 1080.86% | 1765.81% | 403.04% | 236.94% | 25% | 98% | |
| OCF Margin | 38.41% | 844.96% | 1132.29% | 1824.28% | 448.80% | 273.21% | 25% | 98% | |
| Gross Profitability | 32.44% | 21.79% | 19.20% | 18.72% | 18.39% | 16.49% | 8% | 24% | |
| Capex Intensity | 3.05% | 52.46% | 51.43% | 58.47% | 45.76% | 36.26% | 25% | 97% | |
| ▸Returns on Capital · 3 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||||
| ▸Earnings quality · 6 ratios | |||||||||
| ▸Liquidity & coverage · 2 ratios | |||||||||
| ▸Leverage · 2 ratios | |||||||||
| ▸Working capital · 3 ratios | |||||||||
| ▸Capital allocation · 5 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
The five drivers multiply to 6.1% vs reported ROE 6.1%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|---|
| Revenue | CNY 8.66B | CNY 417.1M | CNY 226.5M | CNY 134.4M | CNY 306.0M | CNY 325.6M |
| YoY % | -95.2% | -45.7% | -40.7% | +127.7% | +6.4% | |
| Cost of Revenue | CNY 961.2M | CNY 1.05B | CNY 1.24B | CNY 1.41B | CNY 1.48B | CNY 1.78B |
| YoY % | +9.0% | +17.9% | +14.3% | +5.1% | +20.3% | |
| Gross Profit | CNY 7.70B | CNY 6.19B | CNY 5.71B | CNY 5.77B | CNY 5.56B | CNY 4.67B |
| YoY % | -19.6% | -7.8% | +1.2% | -3.7% | -16.0% | |
| R&D Expense | CNY 1.36B | CNY 1.40B | CNY 1.42B | CNY 1.35B | CNY 1.32B | CNY 1.06B |
| YoY % | +2.5% | +1.4% | -4.8% | -2.2% | -19.3% | |
| Selling & Marketing Expense | CNY 3.25B | CNY 2.76B | CNY 2.87B | CNY 3.01B | CNY 2.99B | CNY 2.53B |
| YoY % | -15.0% | +3.9% | +5.1% | -0.8% | -15.2% | |
| SG&A Expense | CNY 381.8M | CNY 543.8M | CNY 502.3M | CNY 538.0M | CNY 534.8M | CNY 504.0M |
| YoY % | +42.4% | -7.6% | +7.1% | -0.6% | -5.8% | |
| Total Operating Expenses | CNY 4.99B | CNY 4.70B | CNY 4.79B | CNY 4.90B | CNY 4.84B | CNY 4.10B |
| YoY % | -5.8% | +1.8% | +2.4% | -1.2% | -15.3% | |
| Operating Income | CNY 3.15B | CNY 1.78B | CNY 1.25B | CNY 1.14B | CNY 1.00B | CNY 769.3M |
| YoY % | -43.4% | -30.0% | -8.8% | -11.8% | -23.3% | |
| Equity Method Income | -CNY 1.2M | CNY 301,000 | -CNY 49.8M | CNY 29.1M | -CNY 109.1M | CNY 102.8M |
| Pretax Income | CNY 3.54B | CNY 2.18B | CNY 1.76B | CNY 2.00B | CNY 1.69B | CNY 1.53B |
| YoY % | -38.5% | -19.0% | +13.3% | -15.6% | -9.2% | |
| Income Tax | CNY 260.9M | CNY 34.0M | -CNY 61.8M | CNY 72.2M | CNY 63.0M | CNY 141.7M |
| YoY % | -87.0% | -12.7% | +125.1% | |||
| Net Income (incl. NCI) | CNY 3.28B | CNY 2.14B | CNY 1.82B | CNY 1.93B | CNY 1.62B | CNY 1.39B |
| YoY % | -34.6% | -14.9% | +5.5% | -15.7% | -14.4% | |
| Minority Interest (P&L) | CNY 2.3M | -CNY 105.6M | -CNY 30.5M | -CNY 9.9M | -CNY 57.8M | -CNY 52.7M |
| Net Income | CNY 3.28B | CNY 2.25B | CNY 1.86B | CNY 1.94B | CNY 1.68B | CNY 1.44B |
| YoY % | -31.3% | -17.5% | +4.3% | -13.1% | -14.2% | |
| Net Income to Common | CNY 3.28B | CNY 2.15B | CNY 1.81B | CNY 1.88B | CNY 1.62B | CNY 1.39B |
| YoY % | -34.4% | -15.9% | +4.0% | -13.9% | -14.5% | |
| EPS (Basic) | CNY 6.86 | CNY 4.30 | CNY 3.62 | CNY 3.84 | CNY 3.34 | CNY 2.95 |
| YoY % | -37.3% | -15.8% | +6.1% | -13.0% | -11.7% | |
| EPS (Diluted) | CNY 6.83 | CNY 4.29 | CNY 3.62 | CNY 3.83 | CNY 3.33 | CNY 2.93 |
| YoY % | -37.2% | -15.6% | +5.8% | -13.1% | -12.0% | |
| Weighted Avg Shares (Basic) | 477.5M | 499.9M | 499.2M | 490.0M | 484.9M | 470.2M |
| YoY % | +4.7% | -0.1% | -1.8% | -1.0% | -3.0% | |
| Weighted Avg Shares (Diluted) | 479.7M | 500.5M | 499.7M | 491.3M | 486.6M | 472.1M |
| YoY % | +4.3% | -0.2% | -1.7% | -1.0% | -3.0% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| FY20222022-12-31 |
| $0.84 |
| −37.3% |
| derived (paid ÷ diluted shares) |
| FY20212021-12-31 | $1.35 | −0.9% | derived (paid ÷ diluted shares) |
| FY20202020-12-31 | $1.36 | — | derived (paid ÷ diluted shares) |
| Ex-date | Amount | Pay date | Freq | Source |
|---|---|---|---|---|
| 2026-07-02 | $0.6600 | — | annual | licensed |
| 2025-12-31 | $1.20 | 2026-02-19 | ir | licensed |
| 2025-10-20 | $0.5900 | 2025-11-20 | u | licensed |
| 2024-12-31 | $1.15 | — | annual | licensed |
| 2024-07-10 | $0.5700 | — | annual | licensed |
| 2023-12-28 | $1.15 | — | annual | licensed |
| 2023-03-20 | $0.5800 | — | annual | licensed |
| 2022-03-18 | $0.5300 | — | annual | licensed |
